The agenda that creates pharma’s future

150Research Calls

We guarantee our topics are relevant to you – having spent over 150 hours speaking to pharma executives like you.

120Insightful Sessions

Covering everything from big picture to the devilish details. Use the filters to choose which topics get you going.

1Big Theme

‘Medicine is just the beginning’: Let’s find out how pharma can be the total solution and be rewarded for it.

  • 6:45am - 7:15am
  • Day 1
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
eyeforpharma Morning Run. Start your day right and join the eyeforpharma team for a 5k run along Barcelona's beautiful coastline. All levels welcome. Meet at the AC Hotel reception for a 6.45 departure.
  • 7:30am - 8:55am
  • Day 1
  • Exhibition Hall
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
Registration & Meet your peers for a Welcome Coffee
  • 8:55am - 9:05am
  • Day 1
  • Keynote
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
Medicine is just the beginning. 5 bold predictions for what comes next

Paul Simms

Chairman

eyeforpharma

  • 9:05am - 9:35am
  • Day 1
  • Keynote
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
Fireside chat. The digital opportunity: time for a new relationship with customers and innovators
  • Discuss the biggest challenges for the industry in digital transformation especially for customers and patients
  • Allergan’s view on how to embrace the challenges that are facing the industry and when this journey will take Allergan and the industry for years to come

Brent Saunders

CEO

Allergan

  • 9:35am - 10:05am
  • Day 1
  • Keynote
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
Panel: Unite Patients, Providers and Payers to Bring Preventative Care to Life
  • Science and business have aligned to make disease interception a new frontier
  • Why Janssen is advancing its World Without Disease Strategy to spark change now
  • A partner-driven innovation model to predict and preempt disease

Ben Wiegand, PhD.

Global Head, World Without Disease Accelerator

Janssen Research & Development, LLC

Paul McCleverty

Regulatory Lead for Oncology, EMEA

Janssen R&D

Rebecca Fitzgerald

Professor of Cancer Prevention

University of Cambridge, Hutchison/MRC Research Centre, UK

Bharat Tewarie

EVP & Chief Marketing Officer

UCB

  • 10:05am - 10:20am
  • Day 1
  • Keynote
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
eyeforpharma Awards Announcement: Most Valuable Patient Initative, Most Valuable Collaboration & The Patient Champion Award
  • 10:20am - 10:50am
  • Day 1
  • Keynote
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
Coffee Break, Networking Sessions and Interactive Solution Zone
  • 10:20am - 10:50am
  • Day 1
  • Exhibition Hall
    • Digital
The 'Digital First' Exhibition Tour
  • 10:50am - 11:20am
  • Day 1
  • Keynote
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
The Start-up elevator pitches
  • 7 hand-picked startups each have just three minutes to demonstrate disruption and win your support
  • Understand how a strong vision makes the lack of resources only a temporary setback

Start-up Pitches from:

aparito

exact cure


medEngine

medtep


MS Sherpa

Nebula Genomics


xbird

  • 11:20am - 11:40am
  • Day 1
  • Keynote
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
Personalised Medicine - Pharma's New Role in Collaborative Care
  • With more and more fully personalised treatments made available, the relationship between Health Care Providers and the Pharmaceutical Industry is changing dramatically.
  • From the old ""Supplier - Customer"" relations - to now ""Industry Value Network Partners for Collaborative Care"" where patients also increasingly have an important role.
  • Hear from Novartis and Salesforce how this change is enabled already today and how Digital plays a pivotal role in bringing these new treatments to market.

Wolfgang Lippert

Senior Director

Salesforce

Emanuele Ostuni

Head of Europe, Cell and Gene Therapy

Novartis Oncology

  • 11:40am - 12:00pm
  • Day 1
  • Keynote
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
Why does big pharma continue to bury its head in the sand?
  • Evolution vs revolution: what would Darwin recommend for pharma?
  • New business models to aspire to – and experiment with
  • Our responsibility to deliver a connected future for real outcomes

Colin Sims

Senior Vice President, Head, Transversal Corporate Strategy

Sanofi

  • 12:00pm - 12:30pm
  • Day 1
  • Keynote
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
Panel: A new technology-driven pharma industry

Details to be revealed

Zach Weinberg

Co-Founder

Flatiron Health

Colin Sims

Senior Vice President, Head, Transversal Corporate Strategy

Sanofi

Daniel Nathrath

Founder & Chief Executive Officer

Ada Health

Rachel Haurwitz

CEO

Caribou Bio

  • 12:30pm - 12:40pm
  • Day 1
  • Keynote
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
eyeforpharma Awards Announcement: Most Valuable HCP Initiative & Start-up Award Announcement
  • 12:40pm - 1:10pm
  • Day 1
  • Exhibition Hall
    • Commercial
    • Digital
The 'Digital Sales Force Exhibition Tour'
  • 12:40pm - 1:50pm
  • Day 1
  • Exhibition Hall
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
Lunch, Networking Session and Interactive Solution Zone
  • 12:40pm - 1:50pm
  • Day 1
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
Lunch Time Workshop Sessions

Workshop facilitators:

Agnitio

Qstream

  • 1:50pm
  • Day 1
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
Chairman Opening

Snow Companies

Open Health

Deloitte

CapSys Group

  • 2:00pm - 2:40pm
  • Day 1
  • Blue Room
    • Digital
    • Commercial
Panel: The digitally mature sales function: how you can transform sales reps into catalysts
  • How real digital transformation will be dependent on capabilities of your customer-facing teams

Naji Gehchan

Chief Marketing Officer & Bio Medicines Leader - France

Eli Lilly

Patrice Baudry

Executive Vice President G3M

LEO Pharma

Dan Zavodnick

Head of U.S. Legal Department, Sr. Associate General Counsel

Kedrion Biopharma

Oliver Gassner

Head of G4A Digital Health Intelligence EMEA

Bayer

  • 2:00pm - 2:40pm
  • Day 1
  • Pink Room
    • Digital
    • Patients
Panel: From Collision to Collaboration: How Diagnostics, Pharma and Patients Can Succeed Together
  • In the new era of personalized medicine matching the right patient with the right area requires pharma and diagnostic collaboration
  • Understand how the two can collaborate, combine strengths and establish a true partnership that will lead to better patient outcomes

Carole Sian Scrafton

Patient Advocate

Melanie Capewell

Group Head Commercial Development

SYNLAB International

Jesus Sobrino

Spain & Portugal UCB Area Head, Global Patient Experience Lead

UCB

  • 2:00pm - 2:40pm
  • Day 1
  • Green Room
    • Medical Affairs
Panel: Medical as leader: discuss how a centralised medical function can improve dynamics with HCPs
  • See whether a concentrated medical HQ team can equip field teams with the skills and capabilities for more effective interactions
  • Discuss the strategic considerations in maintaining a balance of global and regional approaches

Christopher Keenan

Head, Worldwide Medical Customer Engagement, Medical Capabilities

BMS

Pol Vandenbroucke

SVP, Chief Development Officer

Pfizer Essential Health

Bill Stephens

Managing Director & Head of Commercial Development

Capsys

Emma Booth

European Medical Head of Strategy and Operations

Amgen

  • 2:00pm - 2:40pm
  • Day 1
  • Red Room
    • Data & RWE
    • Market Access
Panel: Understand the acceptability of RWE across global regulatory decision-making
  • Explore the evolving role of RWE in the evidence lifecycle, quality expectations and the possibility of regulatory grade RWE
  • Discuss the impact of regulatory policies, such as 21st Century Cures Act, on the global adoption of RWD into R&D and Access framework

Khair ElZarrad

Deputy Director, Office of Medical Policy

FDA

Giuseppe Rosano

Member CVWP, European Medicines Agency, Consultant Cardiologist, Agenzia Italiana del Farmaco

EMA

Christoph von der Goltz

Senior Director, Head of HEOR & RWE

Lundbeck

Jeremy Rassen

Co-Founder, President, and Chief Scientific Officer

Aetion

Moderator:

Andrew Spiegel

Chair-Elect

IAPO

  • 2:00pm - 3:00pm
  • Day 1
  • Roundtable Zone
    • Commercial
    • Roundtables
Commercial Roundtables
  1. How Pharma can go beyond the pill to provide value-added services
  2. Enable reps to deliver more immersive education with VR tools
  3. Beyond education: become a source of inspiration for HCPs
  4. Customer Experience: measure yourself against the hardest metrics, including loyalty and advocacy
  5. Remove complexity with smarter KAM and MSL coordination
  6. The Biologics revolution - impact on health and the economy
  7. Gender Parity in Action: from Awareness to Outcomes

Roundtable facilitators include:

  • Dr Munna Choudhury, Independent Consultant affiliated with Accenture and Alacramed
  • Carsten Grandke, Senior Director Marketing Communications, Centogene AG
  • Tim Cave, CEO & Founder, SaySo Medical
  • Cyril Mandry, Senior Marketing Director, MSD
  • Guido Senatore, Country Medical Director Spain, Bayer
  • Anita Natzkova, Strategic Insights Lead Global Pharmaceutical, Abbott
  • Ingrid Marchal-Gerez, Regional President, Marketing & Communications, Healthcare Businesswomen's Association
  • 1:55pm - 2:10pm
  • Day 1
  • Innovation Stage in the Expo
    • Health Tech & Innovation
eyeforpharma Awards Case Study Finalist - Most Valuable Patient Initiative "Using machine learning to provide real-time information and guidance"
  • How ALK improved allergy patients’ lives with the first personalised allergy companion app, using data modelling and machine-learning to provide real-time information and guidance

Louise Kristine Hjernø

Head of Digital Projects

ALK

  • 2:10pm - 2:25pm
  • Day 1
  • Innovation Stage in the Expo
    • Health Tech & Innovation
Non-adherence in Diabetes: finding ways to improve patient compliance
  • Find out how big data analytics on internet search behaviors can be used to segment the population on potential non-compliance factors
  • Discover how behavioral profiling can support recommendations on how to address the non-compliance risks specific to each segment

Maurice Straetmans

Vice President Healthcare Industries

Tsquared Insights

  • 2:25pm - 2:40pm
  • Day 1
  • Innovation Stage in the Expo
    • Health Tech & Innovation
eyeforpharma Awards Case Study Finalist - Most Valuable Patient Initiative "How to empower patients and improve conversations with HCPs"
  • See how Novartisand Health Unlimited built an online digital community Speak Your Migraine to improve patient-HCP relationships

Dimitra Mastrantoni

WorldWide Associate Brand Director Migraine

Novartis

Brendan Manning

Account Director

Health Unlimited

  • 2:40pm - 3:00pm
  • Day 1
  • Blue Room
    • Commercial
    • Digital
The key to the future? It lies in a systemic customer centricity
  • Understand how Daichii-Sankyo is actioning a holistic approach to customer centricity
  • Hear about 3 different projects they’re rolling out:
    • NPS targeting towards HCPs
    • Kiku targeting CFRs
    • www.mycancertherapy.eu targeting patients
    • Customer Centricity Score

Dr. Patrik Markt

Executive Strategic Projects and Assistant to the Board

Daiichi Sankyo Europe GmbH

  • 2:40pm - 3:00pm
  • Day 1
  • Pink Room
    • Patients
    • Commercial
    • Market Access
Shape the business landscape
  • Learn how anticipation of policy changes and proactive engagement on advocacy and policy shaping can be a critical source of competitive advantage.

Scott Williams

Vice President , Head of Global Patient Advocacy and Strategic Partnerships

Merck Group

  • 2:40pm - 3:00pm
  • Day 1
  • Green Room
    • Medical Affairs
The evolution of Medical Affairs role in the Medicines Development Process
  • Make development patient-centric and value-oriented with a more strategic approach using Medical leadership
  • Understand the structural and capability requirements for involvement in the complete life cycle from idea generation on

Pol Vandenbroucke

SVP, Chief Development Officer

Pfizer Essential Health

  • 2:40pm - 3:00pm
  • Day 1
  • Red Room
    • Data & RWE
    • Medical Affairs
    • Digital
Machine learning and emerging analytical approaches for Regulatory and Safety RWE
  • Lessons learnt in building internal capacity to accept new technology through training and partnerships
  • How to take advantage of new capabilities to combine, use and extract data while staying compliant and ensuring appropriate impact"

Andrew Bate

Senior Director, Analytics Team Lead, Epidemiology

Pfizer

  • 2:40pm - 3:00pm
  • Day 1
  • Innovation Stage
    • Health Tech & Innovation
Reimburse digital solutions - lessons learnt from Germany’s most successful reimbursement case study
  • Understand how Sonormed successfully gained market access for Germany’s first health product mobile app before it’s even been developed
  • Explore the payer negotiation process and hear feedback from reimbursement considerations shaping product development

Jörg Land

CEO

Sonormed

  • 3:00pm - 4:10pm
  • Day 1
  • Workshop Rooms
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
    • Roundtables
Workshop Sessions (Pharma & Biotech Only)

Each of the below interactive sessions will take place concurrently between 3:00pm – 4:10pm as break-outs from the main agenda (there will be no other talks at this time). Every session will bring together 15-30 pharma and biotech attendees alongside the hosts to deep dive into the particular topic specified below.

These sessions will be the biggest chance at the event to interact, debate and share experiences with your fellow attendees and expert session leaders.

  1. Developing excellence in AI Led by Novasecta
  2. Evolving HCP websites: deliver behaviour changing journeys rather than digital destinations Led by EPG Health
  3. Understand and act on HCP channel preference in the “orchestrated customer environment” - key trends and success factors Led by IQVIA Technologies
  4. Connected content: how to create content beyond systems, channels and devices Led by Viseven Europe
  5. End-to-End processes with Intelligent Automation Led by Appian
  6. The rules of patient engagement: Building trust across the globe Led by Snow Companies, Shire, UCB & Catherine Irwin (Patient speaker)
  7. Use case: Transform real-world data (RWD) into patient care improvement Led by Cegedim
  8. Create better alignment between sales and marketing teams to win the modern customer Led by Showpad
  9. Live Interactive Experience: How digital is revolutionising patient journeys Led by Deloitte & Deloitte ConvergeHealth
  • 3:00pm - 3:30pm
  • Day 1
  • Exhibition Hall
    • Commercial
    • Digital
    • Medical Affairs
The 'Educating HCPs' Exhibition Tour
  • 4:10pm - 4:40pm
  • Day 1
  • Exhibition Hall
    • Data & RWE
    • Health Tech & Innovation
    • Patients
The Innovation Exhibition Tour
  • 4:10pm - 4:40pm
  • Day 1
  • Exhibition Hall
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
Coffee Break, Networking Sessions and Interactive Solution Zone
  • 4:40pm - 5:00pm
  • Day 1
  • Blue Room
    • Commercial
    • Digital
Strengthening growth with advanced analytics and AI
  • Understand how you can further growth in new launches, and how to tackle the opportunities
  • Learn about In-depth practical examples and case studies from key EU markets
  • Delve into what capabilities are needed and what you should start doing tomorrow to address the opportunity

Simon Williams

Founder & Director

QuantumBlack

Reinout Goedvolk

Senior Partner

McKinsey & Company

  • 4:40pm - 5:00pm
  • Day 1
  • Pink Room
    • Patients
    • Commercial
Radical Re-Organisation
  • Use a strategic partner allows organisations to maximise asset value and patient outcomes by optimising resource, being agile and flexible and having a laser-like focusing on what really matters.
  • Understand how the model works across the whole commercial lifecycle of an asset, from launch, through label extension to increasing adherence and driving mature portfolios.
  • Move away from simple supplier relationships to sharing values with aligned goals - focussing on outcomes to business challenges, not transactions."

Dan Spacie

President Selling Solutions, Europe

Syneos Health

  • 4:40pm - 5:00pm
  • Day 1
  • Green Room
    • Medical Affairs
Artificial intelligence: Reality or Hyperbole in Medical Communications
  • Artificial intelligence (AI) is being hailed as a key to reducing the human and economic burden in the drug development process and in clinical practice.
  • Using practical examples, this session covers current applications for AI that are, or will affect medical affairs, including gathering insights from big data, clinical diagnosis and personalized content. The session will share the experience of those developing the technology, where current research might lead and its implications for medical affairs.

Rajni Dogra PhD

Director, Communication Strategy and Planning

Healthcare Consultancy Group

  • 4:40pm - 5:00pm
  • Day 1
  • Red Room
    • Data & RWE
    • Market Access
Patient Access to Innovative Medicines in Europe – Accelerating time to access

Elizabeth Hampson

Director

Deloitte

  • 4:40pm - 4:55pm
  • Day 1
  • Innovation Stage in the Expo
    • Health Tech & Innovation
eyeforpharma Awards Case Study Finalist - Most Valuable Patient Initiative: Creating a patient-centric artificial intelligence (AI) communication chatbot to improve patient support

Understand how Norgine used AI to develop a patient chatbot Ava to provide timely, accessible information to support patients D43

Kym Jacks-Bryant

Global Digital Marketing Lead

Norgine

Veronique Segura

Global Brand Manager

Norgine

Hannah Thompson

Senior Central Medical Affairs Executive

Norgine

  • 4:55pm - 5:10pm
  • Day 1
  • Innovation Stage in the Expo
    • Health Tech & Innovation
What is a spider without its web? Or how one company embraced digital transformation
  • Find out how to transform your communication with HCPs through integration of offline and online activities
  • See how to achieve 9 points of contact per month with HCPs through customized digital content
  • Discover how to multiply the effect of your activities by integrating a single digital solution targeting both HCPs and patients

Alexandra Veleva

CEO

Credoweb

  • 4:40pm - 5:40pm
  • Day 1
  • Roundtable Zone
    • Market Access
    • Roundtables
Market Access Focused Roundtables
  1. Patient + value = payer value: how to articulate new patient journey understanding into a language payers understand
  2. Monopoly vs. Monopsony: risks and opportunities for companies and payers/health systems in joint value assessments and negotiations in Europe
  3. Italy’s outcomes-based experience: deep dive into the challenges and key learnings from the early movers into outcomes-based agreements in Europe
  4. Internal access alignment: discuss how best to pool capabilities and define Market Access responsibilities
  5. Cost containment and affordability barriers across European markets: new trends in market access

Roundtable facilitators include:

  • Agathe le Lay, Director and Head of Health Economics & Outcomes Research, Lundbeck
  • Thomas Temme, Head of Value Demonstration & Access & Public Affairs Germany, Austria & Switzerland, Shire Pharmaceuticals
  • Lara Pippo, Head of Market Access, CSL Behring
  • Ben Wheatley, Associate Director, Four Health
  • Neil Chin-On, Head of Market Access Pharmaceuticals, Novartis
  • 4:40pm - 5:40pm
  • Day 1
  • Roundtable Zone
    • Commercial
    • Roundtables
    • Digital
    • Health Tech
    • Patients
Technology Roundtables
  1. The power of digital health innovation in increasing value to patients and HCPs - are you there yet?
  2. Empowering Patients through data

Roundtable facilitators include:

  • Cristina De Juan, CEO & Founder, IMT Innovation
  • Caroline Schmitt, Medical Science Liaison, Takeda
  • 5:00pm - 5:20pm
  • Day 1
  • Blue Room
    • Commercial
Sandoz Case Study: Commercial Excellence: as strong as the weakest link
  • Understand the end-to-end process and understand that customer centricity as the key lighthouse and everything you need to do to ensure you meet the expected customer experience.

Gabriel Morelli

Global Head of Commercial Excellence

Sandoz International

  • 5:00pm - 5:20pm
  • Day 1
  • Pink Room
    • Patients
    • Commercial
For more than three decades we’ve built more and apparently better inhalers – is it time for a new perspective?
  • What is the challenge
  • Who’s perspective is critical
  • What can we learn from user testing
  • Pointers for the future

Mark Milton-Edwards

Global Commercial Senior Director

TEVA Pharmaceuticals

  • 5:00pm - 5:20pm
  • Day 1
  • Green Room
    • Medical Affairs
    • Patients
Scale Behavioral Change To Leave No Patient Behind
  • Design effective patient programs through personalized behavioural triggers
  • Apply predictive analytics to create patient segments
  • Build the infrastructure for an RWE strategy capable of informing tailored programs at scale

Jennifer Turgiss

Vice President, Behavior Science & Advanced Analytics

Johnson & Johnson Health and Wellness Solutions

  • 5:00pm - 5:20pm
  • Day 1
  • Red Room
    • Data & RWE
    • Market Access
Drive the adoption of RWE
  • Explore key driving forces preventing increased adoption of RWE from a force field perspective
  • Discuss approaches to further build a robust European healthcare data-scape

David Leather

Medical Vice President, Respiratory Franchise

GSK

  • 5:10pm - 5:25pm
  • Day 1
  • Innovation Stage in the Expo
    • Health Tech & Innovation
How a medtech startup has improved the lives of cystic fibrosis patients with remote data
  • Learn from a pioneering approach to cystic fibrosis care via remote data collection from NuvoAirthat has reduced hospital visits and improved patient outcomes

Lorenzo Consoli

Co-Founder, CEO

NuvoAir

Fredrik Aidehag

Director of Products

NuvoAir

  • 5:20pm - 5:40pm
  • Day 1
  • Blue Room
    • Commercial
    • Digital
I wanna hold your hand: people and partnership for the future of pharma
  • Despite our continued focus on digital transformation, what are key barriers to our success and how can we refocus our efforts to gain traction within our organizations? How do we activate the power of the people?
  • Looking beyond our organizations, what does the landscape look like if we succeed in our digital transformations as an industry? What kind of considerations for partnership should we be investigating in order to be competitive and deliver on the customer expectations of today – and tomorrow?

Sari Carter

Head of Marketing

Anthill Agency

  • 5:20pm - 5:40pm
  • Day 1
  • Pink Room
    • Patients
The future of patient services: How pharma can harness technology and innovation to find new patient value
  • The building blocks for successful digital care delivery in the future
  • The transformational, high-value technologies that will come to define us and augment patient care
  • How our business models, patient partnerships and data flow will evolve

Nagore Fernandez Dominguez

Head of Patient Solutions for Europe and Canada.

Ashfield

  • 5:20pm - 5:40pm
  • Day 1
  • Green Room
    • Medical Affairs
Leveraging Online Discussion Platforms for Optimal Publication Planning Execution
  • Identify the logistical and resource barriers to domestic and global participation
  • Learn about innovative communication solutions that leading organizations utilize to overcome these challenges
  • Discuss how to use these solutions to deliver improved publication planning outcomes

Peter Gannon

Senior Vice President, Business Partnerships

Within3

  • 5:20pm - 5:40pm
  • Day 1
  • Red Room
    • Data & RWE
Big Data and Artificial Intelligence - from concept to care

Ignanico Medrano

Neurlogist & Founder

Savanamed

  • 5:25pm - 5:40pm
  • Day 1
  • Innovation Stage in the Expo
    • Health Tech & Innovation
eyeforpharma Awards Winner - Most Valuable HCP Initiative Case Study
  • 5:40pm - 6:00pm
  • Day 1
  • Blue Room
    • Commercial
An end-to-end view to your customer suite
  • Adopt a multi-customer model: Physicians, Payers, Policy Makers and Patients. Integrated multi-customer strategies are the way forward.

Ana Cespedes

Chief Operating Officer

IAVI

  • 5:40pm - 6:00pm
  • Day 1
  • Pink Room
    • Patients
    • Commercial
    • Digital
Develop solution for day to day disease management
  • Let Andrew fly you on board his ‘blood sugar plane’, rising high and dipping low, in order that you can experience a real patient journey and the challenges that had to be overcome.
  • How recognition of a real patient experience led to the creation of a life-changing technical solution and better
  • How a patient’s decision-making process depends on good data feedback and impact on QOL

Andrew Warrington

Digital Therapeutics project leader

  • 5:40pm - 6:00pm
  • Day 1
  • Green Room
    • Medical Affairs
Redefine Medical Value – participant and audience Q&A round-up session
  • Further unpick the days sessions with a round-up discussion involving participants and audience members
  • What is future of medical affairs and how do we take steps now to get there?

Heather Moses

Head of Medical Affairs

Roche

  • 5:40pm - 6:00pm
  • Day 1
  • Red Room
    • Data & RWE
Federated & harmonised real world research in Europe – 2020 and beyond
  • Discuss key challenges and objectives from key European projects (EMIF & EHDEN) in creating a sustainable harmonised EU data ecosystem
  • Explore current and predicted impact IMI European Health Data Network (EHDEN) now underway

Nigel Hughes

Scientific Director, Janssen Clinical Innovation

Janssen R&D

  • 6:00pm - 7:30pm
  • Day 1
  • Exhibition Hall
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
Networking Drinks Reception and Interactive Solution Zone
  • 7:30pm
  • Day 1
  • W Hotel
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
W Hotel Networking Event - Sponsored by Open Health, Snow Companies and Indegene

Sponsored by:

Open Health

Snow Companies

Indegene

  • 6:45am - 7:15am
  • Day 2
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
eyeforpharma Morning Run. Start your day right and join the eyeforpharma team for a 5k run along Barcelona's beautiful coastline. All levels welcome. Meet at the AC Hotel reception for a 6.45 departure.
  • 9:00am - 9:10am
  • Day 2
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
Chairman Opening

Four Health

Alpharmaxim


PA Consulting

  • 9:10am - 9:30am
  • Day 2
  • Blue Room
    • Digital
    • Commercial
The Changing Patient Journey: Are We Keeping Up?

There are now 200B health searches in 2018, over 200M wearable devices sold this year, and countless other stats showing that patients are more educated than ever about their health. Patients are moving faster than ever...are we keeping up?!

Ryan Olohan

Managing Director, Healthcare

Google

  • 9:10am - 9:30am
  • Day 2
  • Pink Room
    • Patients
Patients as your most insightful colleague
  • Learn from the experts - move past the lip-service and instil genuine patient insight into your business planning
  • Establish the relationship between business growth and patient focus, reaffirming belief in your company that it’s the right thing to do for business and patient

Roslyn F. Schneider

Industry Physician, Retired Clinical Professor of Medicine

  • 9:10am - 9:30am
  • Day 2
  • Red Room
    • Data & RWE
    • Medical Affairs
Modernise the development paradigm with RWE
  • Explore how Boehringer are using RWE to complement data from clinical trials with new levels of patient population understanding
  • Enhance development efforts with easily accessible and communicable RWD platforms

Amanda Golembesky

Head of Real World Evidence Analytics Center of Excellence

Boehringer Ingelheim

  • 9:10am - 9:30am
  • Day 2
  • Green Room
    • Medical Affairs
    • Market Access
Go beyond Medicine, how can we create value through partnerships
  • Why success in partnership with Public Institutions like Payers, Hospitals, Universities, Patient associations, other Pharma, Start-ups and tech innovators we will mean value for all stakeholders
  • Hear how the above can catalyze faster and better innovation adoption within pharma – meaning better outcomes and cost effective healthcare solutions

Isabel Torres

Vice President Market Access, Public Affairs and Patient Advocacy for Europe and Canada

Takeda

  • 9:00am - 10:30am
  • Day 2
  • Roundtable Zone
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
    • Roundtables
Design-Thinking Open Workshop

Accelerate innovation by addressing patient and company challenges with design thinking Learn how aspects of design thinking can be applied to generate solutions and solve even the most complex problems in the healthcare environment. Think beyond digital, ensuring your organisation utilises new technology and ways of thinking to enhance the patient journey. Envisage how other industries and companies have embedded design thinking within their organisation, which allows for continuous feedback and improvements to products and services

Roundtable facilitators include:

  • Ute Conradi, Head of the innovation hub “Creative Lab“ / Sr. Lead Operational Excellence, UCB
  • 9:10am - 9:30am
  • Day 2
  • Innovation Stage in the Expo
    • Health Tech & Innovation
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
The first biopharma company to be born in the cloud
  • Understand how Moderna Therapeutics has evolved as a truly digital biopharma organization and what this means for advancing drug candidates to clinical studies; increasing the agility of its research, development, and manufacturing processes; and achieveing results—such as personalized cancer vaccines—that would have been impossible even a few years ago.
  • Lessons learnt from their journey and their vision for the future of the company and what this means for the future pharma business model

Marcello Damiani

CDO

Moderna Therapeutics

  • 9:30am - 9:50am
  • Day 2
  • Blue Room
    • Commercial
    • Digital
The case for Low-Tech: 5 Tactics that will yield more ROI than AI or Blockchain
  • Dive into Product and UX fundamentals! The tech gold rush has flooded conferences around the globe with promises of 'Blockchain-this' and 'AI-that', but organizations need to take a step back and lay strong foundations in order for these new technologies to truly provide incremental value.
  • Help your business grow with new solutions and software that physicians will actually use. We, as life-science stakeholders, need to provide solutions to physicians' authentic, underserved needs – and we need to do so in a way that respects their time and native workflow.
  • Delve into the 5 most important tenets of Product and User Experience design; the low-tech, tried-and-true tactics that engage an audience and lead to meaningful ROI.

Ben Greenberg

Creator of Medscape Mobile

Medscape

  • 9:30am - 9:50am
  • Day 2
  • Pink Room
    • Patients
    • Commercial
    • Digital
    • Data & RWE
    • Health Tech & Innovation
Why Value Based Care means a move to offering Medicine-as-a-Service for Pharma
  • Understand how Pharma must offer services beyond-the-pill to deliver improvements in healthcare outcomes and meet the demands of Value Based Care
  • Delve into the new normal of Medicine-as-a-Service and see how it has been rapidly evolving
  • How Medicine-as-a-Service addresses the challenges that Pharma is facing including: Digital Innovation, RWE, Patient Centricity and much more.

Jim O'Donoghue

President

S3 Connected Health

  • 9:30am - 9:50am
  • Day 2
  • Green Room
    • Medical Affairs
    • Market Access
Analytics and forecasting for efficient business development, early pricing and target product profile optimisation
  • Explore how evidence-based analytics and forecasting can present an alternative to primary research when developing early commercial strategy, promoting faster research, an unbiased starting point and a new approach to engage stakeholders
  • Hear how GPI have transformed the Value Frameworks concept to categorise and quantify HTA outcomes and reimbursement decisions to create powerful analytics that provide fast forecasts for target product profile optimisation and value-based pricing strategies
  • Get introduced to the GPI pulse platform, the vision, data and analytics behind faster and more efficient pricing and access decision making

Henrike Granzow

Director

Global Pricing Innovations

  • 9:30am - 9:50am
  • Day 2
  • Red Room
    • Data & RWE
Emerging Technology to Improve Patient Engagement in Post-Approval Research
  • How do we simplify the process of prosective patient data capture for patients as they participate in post-approval research
  • The role of technology – particularly advancing consumer technologies – in improving patient engagement during post-approval research

Chris Watson

Director of Product Strategy, eCOA

ERT

  • 9:00am - 10:30am
  • Day 2
  • Roundtable Zone
    • Data & RWE
    • Roundtables
Procurement Roundtables
  1. Deliver, prove and maximise ROI on your digital spend
  2. Procurement as the digital transformation catalyst

Roundtable facilitators include:

  • Filiz Saka Crockford, Commercial Procurement Category Lead, Takeda
  • Robert Zimmer, Global Category Manager, Digital Marketing, Novartis
  • 9:30am - 9:50am
  • Day 2
  • Innovation Stage in the Expo
    • Health Tech & Innovation
    • Patients
    • Digital
From the Ward to the World: The potential of remote patient monitoring in digital medicine
  • Understanding the real-world patient journey and response to treatment through remote patient monitoring
  • Emphasising the importance of providing good quality data to pharmaceutical partner
  • Identifying emerging trends within digital medicine and Medopad’s approach to navigating this space

Martha Carruthers

Head of Pharma Partnerships

Medopad

  • 9:50am - 10:30am
  • Day 2
  • Blue Room
    • Medical Affairs
    • Commercial
Panel: The rep of tomorrow, today
  • Fast-track a new paradigm for your sales reps and MSLs
  • Define the balance of responsibilities and objectives throughout your whole field team

Dirk Abeel

Global Medical Sales Director

Reckitt Benckiser

Patrik Grandits

Managing Director, Head Commercial Operations EAME Oncology

Daiichi Sankyo Europe

David Ventura

Head of Marketing Iberia

CSL Behring

  • 9:50am - 10:30am
  • Day 2
  • Pink Room
    • Medical Affairs
    • Patients
The PARADIGM Panel: Indicators for adding value through patient engagement
  • Discuss feasible outcomes of patient engagement in medicine development
  • What are relevant indicators to evaluate whether this outcome can be reached

Dr. Tjerk Jan Schuitmaker-Warnaar

Assistant Professor System Innovations in Health Care, Coordinator Major Science in Society

Athena Institute for Research on Innovation and Communication in Health and Life Sciences

Lars Joensson

Vice President Patient Engagement R&D

Grünenthal Group

Begonya Nafria

Patient Advocacy Manager

Barcelona Children's Hospital

Ramona Kanters

Director

OPEN

  • 9:50am - 10:30am
  • Day 2
  • Green Room
    • Market Access
    • Medical Affairs
Panel: How to work more openly with HTAs to improve patient care and match medical innovation
  • Discuss the changing needs for value assessment as levels of effectiveness increase
  • How to foster more transparent partnership with government bodies

Martin Price

Vice President, Health Economics, Market Access & Reimbursement

Janssen

Adam Kundzewicz

Global Head of Strategic Market Access Initiatives

Boehringer Ingelheim

Stefan Holmstrom

HTA Strategy and PRO Excellence, Head

Astellas

Diar Fattah

Associate Director, Medicines Optimisation (DGS and Swale CCGs)

NHS

Will Hind

Agency Principal

Alpharmaxim

  • 9:50am - 10:30am
  • Day 2
  • Red Room
    • Data & RWE
    • Medical Affairs
Panel: Understand how to prove real-world effectiveness pre-launch
  • Case Study: Explore how phase II of the IMI GetReal programme is developing industry-wide standards and methodologies to accelerate adoption of RWE
  • Discuss how to incorporate RWE into the traditional R&D framework and tools available now to enhance operational efforts

Páll Jónsson

Associate Director Science Policy and Research

NICE

Rob Thwaites

Former Senior Director, Strategy, Global Outcomes Research (GOR) and Head, GI, GOR

Takeda

Wim Goettsch

Special Advisor HTA, ZINL; Affiliate Associate Professor International Collaboration in HTA, Universiteit Utrecht

ZINL

Bengt Annell

Nordic Market Access, Team Lead for Value, Tender and Pricing

Shire

  • 9:50am - 10:30am
  • Day 2
  • Innovation Stage in the Expo
    • Health Tech & Innovation
    • Digital
    • Patients
    • Market Access
Fireside chat: Without the pill: How digital therapeutics can drive market access innovation and herald in a new era of shared value
  • Discuss how the current partnership model is flawed and why we need to be partnering for new kinds of value
  • Find out how the leading organizations are partnering by focusing on the friction and pain points of care, and building value alliances with key stakeholders

David Van Sickle

CEO

Propeller Health

Paul Simms

Chairman

eyeforpharma

  • 10:30am - 11:00am
  • Day 1
  • Exhibition Hall
    • Digital
The 'Digital First' Exhibition Tour
  • 10:30am - 11:00am
  • Day 2
  • Exhibition Hall
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
Coffee Break, Networking Sessions and Interactive Solution Zone
  • 11:00am - 11:20am
  • Day 2
  • Blue Room
    • Digital
    • Commercial
Being disruptive from within- The LEO Innovation Lab story
  • Hear how LEO Innovation Lab ensure agility and how they can continuously drive innovation
  • Find out how they use patient insights to leverage innovative new solutions in AI, assistant tools and machine learning.

John Zibert

Chief Medical Officer

LEO Innovation Lab

  • 11:00am - 11:20am
  • Day 2
  • Pink Room
    • Patients
Establishing true patient outcomes, starting with the patient right from the R&D process
  • Focusing on patient outcomes when designing ‘pharma plus digital’ products
  • Building a patient focused cross-functional agile team to launch a product

Panos Papakonstantinou

Musculoskeletal Mobility Solutions Commercial Director

Novartis

  • 11:00am - 11:20am
  • Day 2
  • Green Room
    • Medical Affairs
    • Digital
Digital transformation – an opportunity for Medical Affairs "
  • Enhancing patient care leveraging DigitalTransforming scientific exchange, medical education and other Medical Affairs activities
  • Establishing a new culture fit for future

Nina Christiane Belly

Global Medical Affairs Digital Transformation Lead

MSD

  • 11:00am - 11:20am
  • Day 2
  • Red Room
    • Data & RWE
    • Market Access
    • Patients
Smarter use of patient data & PROs to build your access case
  • How to move beyond clinical measures and successfully capture what truly matters to patients to secure access

Daniel Jackson

Global Head, Market Access Solutions and Strategy

UCB

  • 11:00am - 11:20am
  • Day 2
  • Innovation Stage in the Expo
    • Health Tech & Innovation
    • Digital
    • Patients
From ‘sickcare’ to healthcare: AI and the future of personalised care
  • Understand how AI can support the shift from reactive ""sickcare"" to the delivery of more people-centric, proactive health management and care
  • Learn how AI-enabled tools will empower the individual to more effectively manage their health
  • Preview how AI can support the earlier identification, prevention and management of chronic and rare disease.

Daniel Nathrath

Founder & Chief Executive Officer

Ada Health

  • 11:20am - 11:40am
  • Day 2
  • Blue Room
    • Commercial
    • Digital
The Age of the Connected Customer- Global Content, systems and data enablement for the new age

Renaud Sermondade

Global Head of Insights and Analytics

Sanofi

Rorik van Welij

Multi-Channel Lead, Europe and APAC

Amgen

Thierry Durand

VP, Omnipresence

Indegene

  • 11:20am - 11:40am
  • Day 2
  • Pink Room
    • Digital
We hear you: responding to customers across a changed communication value chain
  • How can pharma do more to support the needs of HCPs and patients alike with improved content and access?
  • How will emerging technologies and the improved adoption of current technologies help us better communicate and remain competitive?
  • Join this session to better understand how pharma can be a resource through digital channels while remaining compliant.

Sari Carter

Head of Marketing

Anthill Agency

  • 11:20am - 11:40am
  • Day 2
  • Red Room
    • Data & RWE
    • Market Access
Biopharmaceutical Acceleration Model for product development and commercialization
  • Historically, product development has largely been disengaged from commercialization
  • However, in the current environment, health system stakeholders demand both clinical and real-world evidence to inform decisions regarding product use and reimbursement
  • This presentation will describe and illustrate with a case study the benefits of a Biopharmaceutical Acceleration Model approach to product development and commercialization, involving comprehensive evidence development to meet clinical, regulatory, and commercial needs

Erwin De Cock

Principal, Real World and Late Phase

Syneos Health

  • 11:20am - 11:40am
  • Day 2
  • Green Room
    • Medical Affairs
    • Digital
The next-generation digital congress experience 
  • Amplify the value of your congress campaigns with innovative digital content and communications
  • Use relevant, real-time content to engage with your key customers and stakeholders to improve their congress experience

Felix Jackson

Founder and Medical Director

medDigital

  • 11:20am - 11:30am
  • Day 2
  • Innovation Stage in the Expo
    • Health Tech & Innovation
Beyond automation: How Connected Robotic Process Automation (RPA) can improve efficiency, outcomes, and patient relationships
  • RPA is empowering business users to make transformational change without the cost and complexity associated with technology-led projects
  • Imagine how highly-efficient Digital Workers collaborating seamlessly with humans could improve outcomes for your technicians, clinicians, managers, and patients
  • Understand how you can leverage this Intelligent Automation, the combined power of enterprise RPA and class-leading artificial intelligence, to enhance business and clinical processes

Drew Sonden

Partner Solutions Consultant EMEA

Blue Prism

  • 11:40am - 12:50pm
  • Day 2
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
Workshop Sessions (Pharma & Biotech Only)

Each of the below interactive sessions will take place concurrently between 11:40am – 12:50pm as break-outs from the main agenda (there will be no other talks at this time). Every session will bring together 15-30 pharma and biotech attendees alongside the hosts to deep dive into the particular topic specified below.

These sessions will be the biggest chance at the event to interact, debate and share experiences with your fellow attendees and expert session leaders.

  1. Deliver on multichannel's potential: a smarter way to do marketing production Led by Williams Lea Tag
  2. A glimpse behind the curtain: Optimize your digital engagement using real-world customer behavior Led by McCANN Health
  3. Mobilizing AI and machine learning for commercial success in Europe Led by IQVIA
  4. Live Interactive Experience: How digital is revolutionising patient journeys Led by Deloitte & Deloitte ConvergeHealth
  5. Boost HCP multi-channel communication with improved AI application Led by antwerpes AG
  6. Novartis Case Study: STOP Fixing & START Coaching! Led by Novartis & Atomus
  7. Beyond the Talk: How do you enable multidisciplinary teams to confront internal & external challenges to be able to innovate and ultimately be MORE PATIENT? Led by Frontera
  8. How Analytics and Artificial Intelligence can help you to get the right treatment to patients at the right time Led by McKinsey
  9. Unlocking the business model in Connected health Led by Phillips Medisize
  • 11:40am - 12:50pm
  • Day 1
  • Exhibition Hall
    • Patients
The 'Delivering What Patients Need' Exhibition Tour
  • 12:50pm - 1:50pm
  • Day 2
  • Exhibition Hall
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
Lunch, Networking Session and Interactive Solution Zone
  • 12:50pm - 1:50pm
  • Day 1
  • Exhibition Hall
    • Digital
    • Commercial
The 'Digital Sales Force' Exhibition Tour
  • 1:50pm - 2:10pm
  • Day 2
  • Blue Room
    • Digital
    • Commercial
Achieve personalisation through omni-channel, longitudinal & behavioral analysis
  • Establish an Omni-channel customer view, understand customer decision journeys
  • Observe customer behaviors and gather insights over short campaign iterations

Philippe Kirby

Digital Capabilites and Marketing Lead

MSD

  • 1:50pm - 2:10pm
  • Day 2
  • Pink Room
    • Patients
    • Commercial
Convince skeptics and prove the commercial value of a patient-centric approach
  • Obtain senior-level support for patient initiatives by linking efforts to outcomes

Simon Eade

Vice President, Head of Global Commercial Strategy

Actelion

  • 1:50pm - 2:10pm
  • Day 2
  • Green Room
    • Data & RWE
    • Medical Affairs
    • Market Access
Hone your RWE generation strategy in Specialty and Rare Diseases
  • "Use RWE to define clinical trial endpoints and meet Market Access goals in rare diseases
  • Understand the multiple channels and high quality data sources available and usable"

Dirk Vander Mijnsbrugge

VP, Medical Affairs Lead International Developed Markets

Pfizer

  • 1:50pm - 2:10pm
  • Day 2
  • Red Room
    • Data & RWE
    • Market Access
Understand how RWE fits into HTA assessment methodology 
  • Bring it home: use local affiliates to feed into international RWE and access planning
  • Compare and contrast the range of HTA evidence hierarchies across Europe

Wim Goettsch

Special Advisor HTA, ZINL; Affiliate Associate Professor International Collaboration in HTA, Universiteit Utrecht

ZINL

  • 1:50pm - 3:10pm
  • Day 2
  • Roundtable Zone
    • Patients
    • Roundtables
im-patient summit Roundtables
  • Creating inclusion across country, language, culture and ethnic barriers – the evolution of patient story telling
  • How to improve ethnic representation in clinical trials
  • Discuss best and worst case examples of pharma-patient group collaboration
  • Disjointed relationship between pharma and med-tech and impact on patient lives
  • An in-depth look at the efforts made in pain management and how we can better create access to physical therapies
  • The changing space of patient advocacy/organisation corporate responsibility (CR) as influence, regulation and onlookers increase
  • Building an experience-based framework to accelerate the growth/improve chances of success for start-up patient groups and organisations
  • It’s raining digital applications – increase use through more targeted collaborative effort, driven by patient need

Roundtable facilitators include:

  • Rick Harris, Patient Advocate & Ellly
  • Henny van Zuidland -Ordelman, Patient & Advocate
  • Alan Thomas, Ataxia & ME
  • Andrew Spiegel, IAPO
  • Carole Sian Scrafton, Fibro Flutters
  • Linda van de Vliert-Duijts, Patient & Advocate
  • Birgit Bauer, Patient & Advocate
  • 1:50pm - 2:10pm
  • Day 2
  • Innovation Stage in the Expo
    • Health Tech & Innovation
    • Patients
Training our immune system to prevent and cure chronic diseases.
  • Understand that the prevention and management of chronic diseases should focus not only on symptomatic patients but on individuals that do not yet have symptoms.
  • Discuss how this disease-prevention strategy profoundly impacts clinical development, marketing and distribution of products, and new payor models.
  • Appreciate how digital strategies that affect an individual’s behaviour towards lifestyle choices, can enhance adherence to treatment and positively affect clinical outcome

Oliver Siegel

CEO

AFFiRiS

  • 2:10pm - 2:30pm
  • Day 2
  • Blue Room
    • Commercial
    • Digital
Customer Engagement models of the future - The Novo Nordisk Way
  • The commercial model of Pharma is changing. Learn how Novo Nordisk plans to elevate their engagement with customers in the future
  • Customer engagement requires more internal cross-collaboration from various customer facing roles. Learn how Novo Nordisk plans to leverage people and technology – The Novo Nordisk Way

Morten Kruse Sørensen

Head of Global Multi-Channel Excellence and Operations

Novo Nordisk

Morten Lindaa

Principal Technology Solutions NEMEA

IQVIA

  • 2:10pm - 2:30pm
  • Day 2
  • Pink Room
    • Commercial
    • Digital
Global strategies for automation technology: boldly solving major business challenges
  • Separate hype from reality, understand the trends in cognitive automation and how to apply this to your organization
  • Hear how Pharma and Medtech are gaining maximum results and adapting their strategy with the market changes

Catherine Calarco

Senior Director, Industry Strategy and Marketing for Life Sciences

Automation Anywhere

James Dening

VP Europe

Automation Anywhere

Robin Kamath

Senior Director, Market Engagement, Global Commercial Digital & Innovation, Europe, International & Japan

AstraZeneca

  • 2:10pm - 2:30pm
  • Day 2
  • Green Room
    • Data & RWE
    • Medical Affairs
Leading Innovation: The Digital Medicines story
  • Discover how Otsuka and Proteus pioneered an innovative alliance to develop Digital Medicines
  • Identify best practices when uniting the pharma development and business model with digital technology
  • Envisage how Otsuka’s new digital medicine might help patients manage their illness and share valuable, objective data with HCPs

Andrew Wright

VP Digital Medicines, Vice President, Digital Medicine & Medical Device Division

Otsuka Pharmaceutical Companies (U.S.)

David O’Reilly

Chief Platform Officer

Proteus Digital Health

  • 2:10pm - 2:30pm
  • Day 2
  • Red Room
    • Market Access
Reimburse digital solutions - lessons learnt from Germany’s most successful reimbursement case study
  • Understand how Sonormed successfully gained market access for Germany’s first health product mobile app before it’s even been developed
  • Explore the payer negotiation process and hear feedback from reimbursement considerations shaping product development

Jörg Land

CEO

Sonormed

  • 2:10pm - 2:30pm
  • Day 2
  • Innovation Stage in the Expo
    • Health Tech & Innovation
Speed up patient recruitment using AI and Natural Language Processing
  • Up to 50% of Clinical Trials are delayed due to patient recruitment issues.
  • Unstructured text-based Medical Records hold around 85% of patients' clinical information.
  • Discover how IOMED helps you leverage the power of detailed patient data to speed up patient recruitment.

Javier de Oca Catalán

CEO

IOMED Medical Solutions Healthtech

  • 2:30pm - 2:50pm
  • Day 2
  • Blue Room
    • Patients
    • Digital
Achieving empathy in digital: How Novo Nordisk put tone of voice first in mobile patient support
  • Going ‘beyond the drug’ through patient co-creation and integrating behavioral science
  • Using virtual conversation to enhance patient-centricity in a complex environment

Herluf Nis Thomsen

Global Product Lead, Patient Experience Programme, Ozempic®

Novo Nordisk

  • 2:30pm - 2:50pm
  • Day 2
  • Pink Room
    • Commercial
What systemic customer centricity means for the sales rep of the future
  • Understand how Daichii-Sankyo’s holistic approach to customer centricity changes the role of their CFRs
  • Hear about how 3 different projects influence the thinking and acting of sales rep already today
    • NPS targeting towards HCPs
    • Kiku targeting CFRs
    • www.mycancertherapy.eu targeting patients

Patrik Grandits

Managing Director, Head Commercial Operations EAME Oncology

Daiichi Sankyo Europe

  • 2:30pm - 2:50pm
  • Day 2
  • Green Room
    • Data & RWE
    • Medical Affairs
    • Market Access
How high-quality real-world data is accelerating oncology research
  • Learn how Flatiron generates meaningful clinical evidence from the electronic health record
  • Explore how “real-world” control arms are helping reimagine the traditional development paradigm, through case studies from Flatiron Health and industry partners

Shane Woods

Vice President, Life Sciences

Flatiron Health

  • 2:30pm - 2:50pm
  • Day 2
  • Red Room
    • Market Access
Pricing innovation in the face of CAR-T and gene therapy
  • Explore how to implement appropriate outcomes-based pricing models to match treatment innovation
  • Understand the new needs of payers given the increasing levels of complexity in timelines and outcomes

Martin Price

Vice President, Health Economics, Market Access & Reimbursement

Janssen

  • 2:30pm - 2:50pm
  • Day 2
  • Innovation Stage in the Expo
    • Health Tech & Innovation
    • Medical Affairs
    • Commercial
How single-cell transcriptomics will redefine human diseases and unearth novel therapeutic avenues
  • Everything you need to know about The Human Cell Atlas, an ambitious project, funded by the Chan-Zuckerberg Institute and others, to map every cell in the human body and how this could impact how drugs are developed
  • Learn how the single revolution is rewriting our understanding of a human disease ranging from cancer to inflammatory conditions

Hussein Al-Mossawi

Clinical Leader, Rheumatology

Oxford University

  • 2:50pm - 3:10pm
  • Day 2
  • Blue Room
    • Commercial
    • Digital
Making the interactions matter: Evidence and impact
  • The growing volume of scientific data creates a pressing need to elevate scientific communications with memorable stories, experienced through meaningful interactions, cutting through the limitations in our audiences’ lives.
  • This session will discuss drivers behind the industry challenges and strategies and tactics that drive impact throughout medical communications interactions.

Eamon McGoldrick PhD

Communication Strategist

Healthcare Consultancy Group

  • 2:50pm - 3:10pm
  • Day 2
  • Pink Room
    • Commercial
From theory to practice: some real cases of AI Applied to Commercial Excellence

Alessandro De Luca

CIO

Merck Group

Giorgio Pinci

Director Commercial Operations

Merck Italy

  • 2:50pm - 3:10pm
  • Day 2
  • Green Room
    • Data & RWE
    • Medical Affairs
Engineering “regulatory grade” real-world data for the era of precision evidence
  • Discuss how can we use RWD as of the basis of regulatory submissions
  • Learn how RWD can be engineered to use cases at population scale
  • See how AI-enabled technologies can drive new insights into research questions, optimise protocols and identify clinical study sites

Jeff Elton

CEO

Concerto HealthAI

  • 2:50pm - 3:10pm
  • Day 2
  • Innovation Stage in the Expo
    • Health Tech & Innovation
    • Digital
    • Commercial
Fireside chat with Caribou Bio's leading CRISPR genome editing company

Rachel Haurwitz

CEO

Caribou Bio

  • 3:10pm - 3:40pm
  • Day 2
  • Exhibition Hall
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
Coffee Break, Networking Sessions and Interactive Solution Zone
  • 3:40pm - 4:00pm
  • Day 2
  • Blue Room
    • Commercial
Dare to Dare: Redefine your customer approach and get ready for transformation
  • Change your perspective. Engage with patients as the key decision makers they’re becoming, and empower them to make educated decisions about their own health.
  • Go deep to understand the patient journey and core customer needs. Do it well, and the insights can reveal hidden value pools, and possibly force you to change your company strategy
  • Meet the needs of your customers by applying relevant digital tools. Implement by applying a start-up way of working, and it will be rocket fuel for your strategy.

Christina Molt Wengel

Senior Vice President and Head of Global Marketing

ALK Pharmaceuticals

  • 3:40pm - 3:55pm
  • Day 2
  • Pink Room
    • Patients
Societies perception of health is broken – let’s build a new one
  • See how the #PersonBeforePatient initiative is changing societies perception of what health means
  • What does this mean to both patients and pharma beyond current therapeutic realities

Ruth Wilson

Co-founder & Director

PersonBeforePatient

  • 3:40pm - 4:00pm
  • Day 2
  • Green Room
    • Patients
    • Market Access
Accelerate patient access to new treatments – NICE Patient Pathways
  • Discuss pharma’s role in ensuring patient access and care are optimised for newly approved treatments
  • Explore NICE’s new initiative enhancing the clinical/patient guidance for treatment at the point of approval

Sir Andrew Dillon

Chief Executive Officer

NICE

  • 3:40pm - 4:00pm
  • Day 2
  • Red Room
    • Digital
LEO Pharma – Growth Hacking their way to the top
  • Hear how LEO Pharma is hacking their way into better HCP engagement, the results and challenges
  • Understand not only the challenges of building the function and the business case for digital marketing

Kasper Jerlang

Head of Global Digital Marketing and Engagement

LEO Pharma

  • 3:40pm - 4:00pm
  • Day 2
  • Innovation Stage in the Expo
    • Health Tech & Innovation
    • Commercial
What commercial pharma needs to know about blockchain
  • Blockchain is about more than cryptocurrencies – it enables multiple parties to jointly collaborate and transact in near real-time
  • Records in the blockchain are encrypted and linked, addressing the heightened safety and privacy concerns that come with personalized care, patient registries & GDPR

Ben Taylor

CEO

LedgerDomain

  • 3:40pm - 4:40pm
  • Day 2
  • Roundtable Zone
    • Roundtables
    • Commercial
    • Medical Affairs
Field Force Effectiveness Taskforce Roundtables

Explore the evolution of pharma’s medical and commercial field force in a fast-changing external environment:
In an hour-long interactive session hosted by field force leaders understand emerging capability requirements, measure effectiveness and ensure successful interactions

Roundtable facilitators include:

  • Heather Moses, Head of Medical Affairs, Roche
  • Dirk Abeel, Global Medical Sales Director, Reckitt Benckiser, Inc.
  • Chris Keenan, Head, Worldwide Medical Customer Engagement, Medical Capabilities, BMS
  • 4:00pm - 4:20pm
  • Day 2
  • Blue Room
    • Commercial
Leveraging data and experience to bring knowledge and value to HCPs
  • A global approach while staying locally relevant
  • Data driven, leveraging ML/AI
  • Partnering strategically to provide an end-to-end solution

Linda Valenta

Global Team Leader Digital Marketing

Boehringer Ingelheim

  • 3:55pm - 4:20pm
  • Day 2
  • Pink Room
    • Patients
Fireside chat: Improve patient adherence with greater collaboration with carers
  • Learn how better to work with caregivers to collect data and insights on the patient journey
  • Discuss the vital role collaboration with caregivers can play in communicating and working with patients
  • How to incorporate carers into clinical trial recruitment processes to enhance timelines and accuracy of patient profiles

Sonia Hawkins

Carer

Vanessa Pott

Director, Patient Advocacy and Strategic Partnerships, Merck

Merck Group

Lode Dewulf

Chief Patient Officer

Servier

  • 4:00pm - 4:20pm
  • Day 2
  • Green Room
    • Data & RWE
    • Market Access
Pre and Post First Approval Access Options: Industry Trends, Considerations, Benefits and Challenges
  • How to support launch strategy with Named Patient Programs (NPPs) and when it’s appropriate to consider this approach
  • Learn How real-world data can be collected from NPPs to support launch strategy through case examples
  • How to find best fit partners to support access/NPPs in Non-launch and/or Lower Priority Markets

Kieron Lewis

Alliance Director

Clinigen

  • 4:00pm - 4:20pm
  • Day 2
  • Red Room
    • Patients
    • Commercial
Optimising launch effectiveness

Graham Morris

President EU5

STEM Healthcare

  • 4:00pm - 4:20pm
  • Day 2
  • Innovation Stage in the Expo
    • Health Tech & Innovation
Two ways that blockchain can transform pharma
  • Live demo of a global supply chain application that passes medication from manufacturers to suppliers to patients – this not only sets the stage to drive down out-of-stocks and counterfeits, but also the advent of personalized medicines
  • Clinical study supply chains managed through blockchain make it possible to replace paper without compromising security or double-blind requirements
  • Blockchain-based patient registries can provide safe and secure sandbox for AI, machine learning on aggregated data sets.

Ben Taylor

CEO

LedgerDomain

  • 4:20pm - 5:00pm
  • Day 2
  • Blue Room
    • Commercial
    • Digital
Panel: Streamlining of customer experience with an omnichannel approach
  • Envision how an industry leading company has created a truly integrated omni-channel offering
  • Equip different departments to begin the omni-channel transition and ensure the required capabilities are in place
  • Tailor your marketing strategy to ensure alignment between various platforms to ensure a seamless, consistent and effortless user experience

Florent Edouard

SVP, Global Head of Commercial Excellence and Customer Engagement

Grünenthal Group

Philippe Kirby

Digital Capabilites and Marketing Lead

MSD

Frédéric Ohayon

Director, Digital, Multchannel & CRM

AstraZeneca

  • 4:20pm - 5:00pm
  • Day 2
  • Red Room
    • Commercial
    • Digital
    • Patients
Panel: Enable your sales force to find traction by aligning with the patient journey
  • How successful reps will combine performance techniques with patient understanding

David Ventura

Head of Marketing Iberia

CSL Behring

Irina Osovskaya

Global Director of Mobile and Customer Experience Strategy

AstraZeneca

Victoria Guyatt

Head of Ethnography

Ipsos

Mary Lynne Van Poelgeest-Pomfret

President

World Federation for Incontinent Patients

  • 4:20pm - 5:00pm
  • Day 2
  • Green Room
    • Market Access
    • Data & RWE
Panel: Drive market access innovation in a risk averse environment
  • Explore the next steps in creating an environment capable of successfully enacting more outcomes-based agreements
  • Strengthen stakeholder alignment with understanding of the groundwork capabilities needed for data needs

Ruediger Papsch

Senior Director | Global Head Market Access & Pricing Fertility

Merck Group

Ulf Staginnus

Senior Vice President, Head Global Market Access & Pricing

Ipsen

Anant Murthy

VP, Market Access, Pricing & Policy, General Manager BE/NL/LU

Alnylam Pharmaceuticals

Sir Andrew Dillon

Chief Executive Officer

NICE

  • 4:20pm - 5:00pm
  • Day 2
  • Pink Room
    • Patients
    • Data & RWE
Panel: Secure data sovereignty for greater health data access and benefits
  • Understand public perception concerns around data security, privacy and use preventing cloud adoption and larger scale data sharing
  • Explore communication approaches and technical solutions to solve perception issues
  • Discuss GDPR’s impact on industry data use and public concerns one year on

Chris Carrigan

Patient Advocate & Researcher

Use My Data

David Leather

Medical Vice President, Respiratory Franchise

GSK

Richard Stephens

Consumer Lead and Chair of Consumer Forum

NCRI

Nigel Hughes

Scientific Director, Janssen Clinical Innovation

Janssen R&D

  • 4:20pm - 4:40pm
  • Day 2
  • Innovation Stage in the Expo
    • Health Tech & Innovation
An industry interface into Population Genomics at scale

The Genomic Medicine Future: How to balance industry requirements with other key stakeholder groups who also have a critical role to play in preparing healthcare systems

  • Hear a definition and key characteristics of population genomics programmes
  • See examples from across EMEA – including operational features
  • Understand what the industry requirements are
  • Leave with an understanding of “What works well?” and “even better if …” from a leading expert in population genomics programmes

Paul Jones

Director, Population Genomics

Illumina

  • 4:40pm - 5:00pm
  • Day 2
  • Innovation Stage in the Expo
    • Health Tech & Innovation
Genomics and Blockchain: Decentralized genomic big data storage, sharing and analysis
  • Look into the future state of genomic data sharing and security as new technological advancements at the intersection of healthcare and information technology are developed.
  • Describe how blockchain technology can enable genomic data creation, ensure its security, and allow for its sharing
  • Discuss the future state of genomic research, genomic data security, genomic data standardization and data sharing between individuals and companies as whole genome sequencing costs continue to decrease.

Dennis Grishin

Co-Founder

Nebula Genomics

  • 5:00pm - 5:25pm
  • Day 2
  • Blue Room
    • Commercial
    • Patients
How to infuse the human perspective to digital health

Oliver Gassner

Head of G4A Digital Health Intelligence EMEA

Bayer

  • 5:00pm - 5:25pm
  • Day 2
  • Red Room
    • Digital
    • Commercial
The bottom-up approach to driving commercial digital transformation as a global team
  • Driving business change based on local business cases rather than a one-size-fits-all – with results
  • Practical applications of AI and automation to drive local business value
  • Working with all levels – from General Managers to Marketers - to change the ways of working
  • The hidden roadblocks and time saps in a true digital transformation

Lanre Ibitoye

Director , Head of Digital Platforms and Capabilites- Europe & International Markets

Teva

Davidek Herron

Head of Outbound Digital Channels, Europe and Interantional Markets

Teva

  • 5:00pm - 5:25pm
  • Day 2
  • Green Room
    • Market Access
    • Data & RWE
    • Medical Affairs
Advance data generation by unlocking the value of academic collaboration

Thomas D'Hooghe

Vice President and Head, Global Medical Affairs Fertility

Merck Group

Prof Manuela Simoni

KOL, Dept. of Biomedical, Metabolic and Neural Sciences

University of Modena

  • 5:00pm - 5:40pm
  • Day 2
  • Pink Room
    • Patients
    • Digital
Panel: Pharma’s generation gap
  • Gain a more complete understanding of population health through enhanced partnership with young patients and carers
  • Learn what new communication channels, approaches and capabilities will be necessary to overcome current industry lacking

Brad Gudger

Founder and Medical Director

Alike

Mieke Karremans

Advocate & Carer

  • 5:00pm - 5:20pm
  • Day 2
  • Innovation Stage in the Expo
    • Health Tech & Innovation
The data revolution in clinical trials
  • Eliminate stagnation through real-time access
  • Optimize performance with Metaprise Analytics
  • Drastically reduce barriers to new therapies
  • Medable E2E: First and only end-to-end cloud platform for clinical trials

Michelle Longmire

CEO

Medable

  • 5:20pm
  • Day 2
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
Networking Drinks Reception and Interactive Solution Zone
  • 9:10am - 9:15am
  • Day 3
  • Keynote
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
Chairman Opening

Paul Simms

Chairman

eyeforpharma

  • 9:15am - 9:55am
  • Day 3
  • Keynote
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
We fight for the patient – and the patient fights for us
  • How the smartest companies are able to go beyond empowerment, beyond advocacy and work with patients for sustained access in a virtuous circle
  • Why your goal must be to have the most comprehensive patient insights if you are ever going to gain trusted partner status

Marc Princen

Executive Vice President and President, International Business

Allergan

Penney Cowan

Founder & CEO - American Chronic Pain Association & Chair

Chair International Alliance of Patient Organizations

Gitte Aabo

President & CEO

LEO Pharma

Dr. Cary Adams

CEO

UICC

  • 9:55am - 10:15am
  • Day 3
  • Keynote
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
"Broad AI + Data" - A powerful combination to drive value in Life Sciences
  • Broad data vs big data and the impact on AI within Life Sciences
  • Leveraging RWD, Advanced Analytics, and Augmented Intelligence to increase efficiency from Research to Commercialization
  • Enabling precision medicine leveraging multi-parametric data analytics & AI

Christina Busmalis

Director, Global Life Sciences

IBM Watson Health

  • 10:15am - 10:25am
  • Day 3
  • Keynote
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
eyeforpharma Awards Announcement: The Lifetime Achievement Award
  • 10:25am - 10:55am
  • Day 3
  • Keynote
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
The Path Forward in Digital Health
  • How today’s ecosystem must change to enable true adoption of transformative digital health solutions
  • Introducing stronger design principles with new Guiding Principles for Ethics in Digital Health
  • How new partnerships will get us to scale and sustainability – but only with effective, ethical leadership

Andrew Thompson

Co-Founder and CEO

Proteus Digital Health

Kabir Nath

President and CEO

Otsuka North America

  • 11:00am - 11:30am
  • Day 3
  • Exhibition Hall
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
    • Roundtables
Coffee Break, Networking Sessions and Interactive Solution Zone
  • 11:30am - 11:50am
  • Day 3
  • Keynote
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
    • Roundtables
Re-wire the organizational DNA to unlock new growth code for life sciences
  • Explore how an empathy driven patient view can be a catalyst for innovation and evolve business models
  • Understand the metrics that matter that demonstrate value to patients and drive business outcomes

Vyom Bhtua

Global Partner, Commercial Life Sciences

Cognizant

  • 11:50am - 12:10pm
  • Day 3
  • Keynote
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
Fireside Chat: The role population genomics plays in the future of pharma

Paul Jones

Director, Population Genomics

Illumina

  • 12:10pm - 12:30pm
  • Day 3
  • Keynote
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
WINNER PRESENTATION: eyeforpharma Start-up Award
  • Thursday, March 14th
  • 12:30pm - 1:00pm
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
Keynote Address Jannsen

Kris Sterkens

Company Group Chairman, EMEA

Janssen

  • 1:00pm - 2:30pm
  • Day 3
  • Keynote
    • Keynotes
    • Commercial
    • Digital
    • Patients
    • Medical Affairs
    • Market Access
    • Data & RWE
    • Health Tech & Innovation
    • Roundtables
Seated lunch networking banquet & end of conference